Managing Editor
@ShahidNShah
@ShahidNShah
0-50Hospitals and Health Care
1110 SE Cary Pkwy, Suite 205, Cary, North Carolina, North Carolina, United States
OncoHost’s proprietary platform, PROphet®, is a plasma-based, proteomic pattern analysis tool whose initial offering in non-small cell lung cancer (NSCLC) uses a single blood sample to guide first-line immunotherapy decision-making. The PROphet® NSCLC test provides clear clinical utility by offering physicians crucial guidance on the optimal first-line immunotherapy treatment plan for each individual patient, with a significant effect on overall survival.
The PROphet report shows a prediction of the patient’s clinical benefit (progression-free survival 12 months) from PD-1PD-L1 inhibitor immunotherapy-based treatment plans.Combining these findings with …
Posted Oncology Allergy and Immunology
Last Updated
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Jul 1, 2025 at 1:20pm